Sexual role and HIV-1 set point viral load among men who have sex with men. by Stansfield, Sarah E et al.
UCLA
UCLA Previously Published Works
Title
Sexual role and HIV-1 set point viral load among men who have sex with men.
Permalink
https://escholarship.org/uc/item/5980m4kp
Journal
Epidemics, 26(2)
ISSN
1755-4365
Authors
Stansfield, Sarah E
Mittler, John E
Gottlieb, Geoffrey S
et al.
Publication Date
2019-03-01
DOI
10.1016/j.epidem.2018.08.006
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Sexual role and HIV-1 set point viral load among men who have 
sex with men
Sarah E. Stansfielda,*, John E. Mittlerb, Geoffrey S. Gottliebc, James T. Murphyb, Deven T. 
Hamiltond, Roger Detelse, Steven M. Wolinskyf, Lisa P. Jacobsong, Joseph B. Margolickh, 
Charles R. Rinaldoi, Joshua T. Herbeckj, and Steven M. Goodreauk
aDepartments of Anthropology & Epidemiology, University of Washington, 314 Denny Hall, Box 
353100, Seattle, WA 98195-3100, USA
bDepartment of Microbiology, University of Washington, Seattle, WA 98195, USA
cDepartments of Medicine & Global Health, University of Washington, Seattle, WA 98195, USA
dCenter for Studies in Demography and Ecology, University of Washington, Seattle, WA 98195, 
USA
eDepartment of Epidemiology, University of California School of Public Health, Los Angeles, CA, 
90024, USA
fDivision of Infectious Diseases, Department of Medicine, Northwestern University Feinberg 
School of Medicine, Chicago, IL, 60611, USA
gDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, 
Baltimore, MD, 21205, USA
hDepartment of Molecular Microbiology and Immunology, Bloomberg School of Public Health, 
Johns Hopkins University, Baltimore, MD, 21205, USA
iDepartment of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of 
Public Health, Pittsburgh, PA, 15261, USA
jDepartment of Global Health, University of Washington, Seattle, WA 98195, USA
kDepartment of Anthropology, University of Washington, Seattle, WA 98195, USA
Abstract
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
*Corresponding author: sestans@uw.edu (S.E. Stansfield).
Contributors
SES led the analysis, including simulations, data analysis, writing, and editing. SMG contributed to research question formation, 
simulations, data analysis, writing, and editing. JEM, GSG, JTH contributed to the conceptual development of the project and to 
manuscript writing and editing. DTH contributed to the data analysis, manuscript writing and editing and to the conceptual 
development of the project. JTM was the main programmer for the EvoNet project and contributed to manuscript writing and editing. 
RD, SMW, LPJ, JBM, CRR oversaw data collection and contributed to the writing and editing of the manuscript. All authors have 
approved the final manuscript.
Conflict of interest
The authors have no conflicts of interest to declare.
Appendix A. Supplementary data
Supplementary material related to this article can be found, in the online version, at doi:https://doi.org/10.1016/j.epidem.2018.08.006.
HHS Public Access
Author manuscript
Epidemics. Author manuscript; available in PMC 2019 May 28.
Published in final edited form as:
Epidemics. 2019 March ; 26: 68–76. doi:10.1016/j.epidem.2018.08.006.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Background: HIV-1 set point viral load (SPVL) is a highly variable trait that influences disease 
progression and transmission risk. Men who are exclusively insertive (EI) during anal intercourse 
require more sexual contacts to become infected than exclusively receptive (ER) men. Thus, we 
hypothesize that EIs are more likely to acquire their viruses from highly infectious partners (i.e., 
with high SPVLs) and to have higher SPVLs than infected ERs. Methods: We used a one-
generation Bernoulli model, a dynamic network model, and data from the Multicenter AIDS 
Cohort Study (MACS) to examine whether and under what circumstances MSM differ in SPVL by 
sexual role.
Results: Both models predicted higher SPVLs in EIs than role versatile (RV) or ER men, but 
only in scenarios where longer-term relationships predominated. ER and RV men displayed 
similar SPVLs. EI men remained far less likely than ER men to become infected, however. When 
the MACS data were limited by some estimates of lower sex partner counts (a proxy for longer 
relationships), EI men had higher SPVLs; these differences were clinically relevant (> 0.3 log10 
copies/mL) and statistically significant (p < 0.05).
Conclusions: Mode of acquisition may be an important aspect of SPVL evolution in MSM, with 
clinical implications.
Keywords
HIV-1; Network modeling; Mathematical modeling; Men who have sex with men (MSM); Sexual 
role; MACS study; Set point viral load
1. Introduction
Viral load (VL)—the density of HIV-1 particles in an infected person’s peripheral blood 
plasma—varies over time and across individuals. Set point viral load (SPVL)—the average 
viral load during the period shortly after acute HIV-1 infection—also varies. Individuals 
with higher SPVLs average faster disease progression in the absence of treatment 
(Modjarrad et al., 2008), while higher plasma VL is associated with higher rates of 
transmitting HIV-1 (Fideli et al., 2001; Quinn et al., 2000). This viral evolutionary trade-off 
spawned the hypothesis that, after introduction of the virus into a treatment-naïve 
population, HIV-1 evolves to intermediate SPVL values; one model found that, for their 
proposed relationship between VL and transmission, SPVL evolved to a value (4.52) close 
to the mean observed within some empirical populations (Fraser et al., 2007).
Nonetheless, SPVL varies greatly among infected individuals, as influenced by host HLA 
and CCR5 genotypes (Blanpain et al., 2002; McLaren et al., 2015; Sabeti et al., 2005), age 
(Hollingsworth et al., 2010), sex (Gandhi et al., 2002), repeated exposure (Hasselrot et al., 
2010; Pala et al., 2013), concurrent STI infection (Roberts et al., 2012), and viral genotype 
(Fraser et al., 2014; Touloumi et al., 2013). Intra-host meta-population dynamics may also 
play a role (Lythgoe et al., 2016). Heritability in SPVL between HIV-1 donor and recipient
—that is, the proportion of the variation in SPVL among individuals that is attributable to 
variation in the viral genotype—is maintained despite the wide range of host responses 
(Bonhoeffer et al., 2015; Hollingsworth et al., 2010; Lingappa et al., 2013; Yue et al., 2013). 
Although individual genome studies have presented widely varying estimates of heritability, 
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one meta-analysis (Fraser et al., 2014) demonstrated that much of this apparent discrepancy 
is explained by differences in reported metrics; a re-analysis of heritability estimates using a 
common definition for the classic h2 measure of heritability across serodiscordant couples 
studies obtained a pooled estimate of 33% (95% confidence interval, 20–46%).
One additional potential source of variation in individual SPVL is the route of HIV-1 
acquisition—e.g. insertive vs. receptive role during anal intercourse (AI). These routes entail 
different mean acquisition probabilities (receptive much higher), while the probability for 
any individual act depends on the transmitting partner’s current viral load (VL) (Baggaley et 
al., 2010; Patel et al., 2014). Although the exact functional form linking VL to transmission 
probability is debated, there is consensus that transmission risks increase monotonically with 
VL (Fraser et al., 2007; Hughes et al., 2012). Following on a concept introduced in Carlson 
et al. (2014), we hypothesize that someone who is at high risk of HIV-1 acquisition (e.g., an 
exclusively receptive male) is more likely to get infected during one of their earliest 
exposures, and thus to acquire a subset of circulating viruses that is relatively unbiased with 
respect to fitness. A person engaging in sexual acts with lower transmission risk may require 
more contacts on average before getting infected, or be disproportionately infected during 
scenarios with higher transmission probability, i.e. during acute infection or from partners 
with very high SPVL (Ma et al., 2009; Wawer et al., 2005). The latter effect could 
theoretically cause sub-populations infected by different routes to have different mean 
SPVLs (MSPVL).
Indirect evidence for this hypothesis may come from heterosexual transmission. Analyses 
have found women to have higher per-act risk of acquisition than men during penile-vaginal 
sex (Patel et al., 2014), and average lower SPVL (Gandhi et al., 2002). One study found that 
viruses transmitted female-to-male contain amino acid variants reflecting higher mean 
fitness than those transmitted male-to-female (Carlson et al., 2014), demonstrating the 
transmission bottleneck’s evolutionary impact and suggesting the potential for SPVL in 
transmitted strains to differ by sex through similar mechanisms. However, alternative 
explanations for SPVL sex differences exist. These include higher estrogen concentrations in 
women, which may reduce TNFα concentration (Shanker and Adams, 1994) and thus viral 
expression (Folks et al., 1989; Mellors et al., 1991), and higher progesterone concentration, 
which could inhibit CCR5 expression (Portales et al., 2001), lowering VL (Jackson, 2015). 
Some studies of persons who inject drugs (PWIDs) show lower SPVL for women 
(Farzadegan et al., 1998), supporting endocrine-mediated mechanisms over transmission 
bottleneck selection. However, other studies found no significant sex differences in PWID’s 
SPVL (Moroni, 1999), and those found could be due to sexspecific cocaine and opiate 
usage, which upregulates HIV-1 replication (Peterson et al., 1991, 1990).
To our knowledge, the question of acquisition mode and SPVL has not been explored among 
men who have sex with men (MSM), even though the effects may be larger among MSM 
than heterosexuals, as the acquisition probability differential via receptive vs. insertive AI is 
greater than the same differential (receptive vs. insertive) for vaginal intercourse (Patel et al., 
2014). Moreover, MSM are less constrained than heterosexuals in terms of transmission 
chains alternating by sexual role (Goodreau and Golden, 2007). For heterosexuals, males 
and females represent each other’s source viral pool, and evolution in one group should 
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change the substrate for evolution in the other, holding divergence in check. For MSM, 
however, an individual man could be infected through receptive AI, allowing transmission of 
a viral genotype that maintains a relatively low SPVL, and then transmit through insertive 
AI, allowing his receptive partner to acquire the same low-SPVL genotype. The resulting 
dynamics are thus less intuitive than for heterosexual transmission. Teasing them apart may 
provide theoretical insight into SPVL dynamics, as well as provide an additional explanation 
for unexplained but clinically relevant SPVL variation. It might also help disentangle 
hypotheses about SPVL differences by sex for heterosexuals.
In this paper, we use a combination of mathematical modeling and empirical data analysis to 
explore differences in HIV-1 SPVL among exclusively insertive (EI), exclusively receptive 
(ER), and role versatile (RV) MSM.
2. Methods
Our methods comprise three parts: a basic one-generation model to gain insight about 
expectations under different assumptions; a more complex, data-driven dynamic network 
simulation to understand SPVL evolution in a linked system between groups; and an 
empirical analysis of SPVL measures in an HIV-1 incidence cohort, by self-reported sexual 
role.
2.1. One-generation model
Our first model was purposely simple in order to gain theoretical insight, and was not based 
on empirical data. It is a stochastic agent-based pair-formation Bernoulli model of one 
generation of HIV-1 transmission from a founder population. Code was written in R and is 
available at github/EvoNetHIV/RoleSPVL/OneGenModel.
We seeded an initially-infected population of 100,000 men with SPVLs (log10 copies/mL) 
distributed at random using a beta function with mean 4.5 and range 2–7. We then simulated 
an equally sized pool of HIV-1-negative men engaging in condomless AI acts with the 
HIV-1-positive men, comparing runs where the negative men were EI vs. ER. We varied the 
number of acts per negative man between 1 and 104, the order of magnitude we considered a 
reasonable upper limit. Values for numbers of acts were concentrated at the lower end of the 
scale to provide more insight into mean population SPVL where it was changing most 
quickly. We considered one scenario in which all acts for an HIV-1-negative man were with 
the same partner, and another in which the HIV-1-negative men randomly select a new 
partner for each act. Transmission probability depended on each partner’s sexual role, the 
number of acts in the relationship, and the HIV-1-positive partner’s SPVL using a modified 
version of the function in Fraser et al. (2007). Their function focused on vaginal intercourse 
(VI) and assumed equal risk for insertive (male) and receptive (female) VI. To convert this to 
AI, we added two relative risks from Patel et al. (2014), which estimated receptive and 
insertive AI to have 23.0 and 1.8 times higher acquisition risks per serodiscordant act than 
VI, when the latter is averaged by role. Fraser’s model was also per-time-period, and we 
back-calculated approximate per-act estimates following our earlier models (see 
Supplementary section S4). The population had no mortality, arrivals, or departures. As the 
population was large and the events independent, we did not repeat simulation runs.
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2.2. Dynamic network model
The one-generation model fostered development of basic insight about the relationship 
between role and SPVL. However, it assumed 100% heritability and complete role 
segregation, i.e. it did not include RV men. It also ignored the stages of HIV-1 infection that 
are marked by changes in VL and transmission probability. Moreover, it could not account 
for the fact that transmissions are a linked system: changes in VL in one generation of 
transmission changes the source VLs for the next. To explicitly address these points in a 
more realistic and empirically-parameterized context, we extended a stochastic, dynamic, 
network-based model described previously (Herbeck et al., 2018). This code builds upon the 
EpiModel (Jenness et al., 2016a) and statnet (Handcock et al., 2008, 2016) R packages and 
is available at github/EvoNetHIV/RoleSPVL. Full methods for this model are found in 
Supplement Sections S1–Supplement Sections S8.
Model parameters governing sexual network structure, sexual role categories and other 
behavioral parameters, and agent attributes were obtained primarily from two modeling 
studies of HIV among US MSM, either directly from Jenness et al. (2016b) or by obtaining 
weighted means of race-specific values in Goodreau et al. (2017). Empirical data for these 
parameters came from two studies of Atlanta-area non-Hispanic Black and White MSM 
conducted 2010–2014 (Hernandez-Romieu et al., 2015; Sullivan et al., 2015).
Agents were defined by a variety of attributes (e.g. age, CD4+ cell count); key ones included 
sexual role (EI, ER, RV), SPVL, and current VL. Sexual network structure was modeled 
with separable temporal exponential random graph models (STERGM) (Krivitsky and 
Handcock, 2014), as implemented in statnet. We simulate a dynamic model that maintains 
the desired network features stochastically. Partnership formation occurred to preserve mean 
momentary degree (0.70, the average number of relationships a man is in at a cross-section 
of time), with partnerships between two EI men or two ER men forbidden. Coital acts 
occurred stochastically within partnerships with probability 0.4/day, but terminated at late-
stage AIDS. The number of arrivals followed a Poisson distribution with mean set to give 
1% population growth, while departures occurred through AIDS mortality, background 
mortality, and aging out. Relational dissolution occurred with a constant hazard, leading to 
geometrically distributed relationship durations. We explored mean relationship durations 
between 50 and 3000 days (corresponding roughly to 20–1200 coital acts/relationship given 
coital frequency). The transmission function matched that used in our one-generation model. 
Recipient SPVL had both inherited and non-inherited components, with heritability = 0.36 
based on one study (Hollingsworth et al., 2010); we note this is very similar to the 
subsequent meta-analysis value of 0.33 described above (Fraser et al., 2014). We did not 
explicitly model host HLA or other host genetic factors, as we have no expectation that these 
would systematically differ between EI and ER men. However, we note that non-viral-
genetic factors influencing SPVL are implicitly modeled within the non-inherited 
component of SPVL variation. MSPVL in the initial population was 4.5.
VL varied continuously through time, following a set of parameters described in the 
Supplement (section S6) and in Herbeck et al. (2018). We modeled four CD4+ cell 
categories, with transition times dependent on SPVL; CD4+ cell category governed 
progression and mortality. The model excluded treatment, as our goal was to understand the 
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basic evolutionary dynamics more clearly. Not including treatment also allowed us to 
compare results to the MACS data, where infections in men in our analysis mainly predate 
the onset of treatment. The population had 1000 individuals aged 18–50, with 20% initial 
HIV-1 prevalence; population size was smaller than for the one-generation model given 
much higher computational burden. Simulations were run in one-day timesteps, with results 
compiled from years 2–5 of the simulation; we ran 50 simulations for each relationship 
duration value. All other parameters were fixed at the point estimates derived from our 
literature review.
2.3. MACS analysis
Finally, we conducted an empirical analysis of data from the Multicenter AIDS Cohort 
Study (MACS) (Kaslow et al., 1987), an ongoing prospective cohort study begun in 1984 
among MSM in four US cities. Participants are asked to return every 6 months for HIV-1 
testing (including VL measurement) and a behavioral survey. Our initial dataset had 712 
individuals, comprising men who entered the study HIV-1-negative and who have 
seroconverted during the course of the study (Table 1).
We defined the interval between last negative visit and first positive visit as the 
seroconversion interval. While the size of this interval is designed to be 6 months, it varies in 
practice, sometimes widely. We thus restricted our sample to men for whom a last HIV-1-
negative and first HIV-1-positive visit were strictly less than 1 year apart (i.e. maximum 364 
days), in order to limit the uncertainty in seroconversion timing; this reduced our sample size 
to 535. The distribution of the seroconversion interval size is shown in Fig. 1; this 
concentrates around 6 months given the study design, and maxes out at < 1 year given our 
inclusion criterion. Seroconversion could occur anywhere within the interval. We estimated 
SPVL by using VL measures for study visits between 6 and 18 months after the midpoint of 
the seroconversion interval (Herbeck et al., 2008). If two visits fell in the interval, their log10 
measures were averaged. For men following the 6-month visit schedule perfectly, our 
method ensures that the VL measures fall approximately 9 and 15 months post 
seroconversion, since actual seroconversion could have occurred anywhere in the 
seroconversion interval. For men with more variable follow-up schedules, our SPVL could 
in theory fall quite early after seroconversion. We thus separately checked durations of the 
time between the first HIV-1-positive visit and first VL measure included in our SPVL 
calculation for each man in the analysis, and determined that only one of these was < 90 
days (our estimate of acute phase infection duration). This man’s interval was 87 days, and 
his first viral load reading (5.02) was slightly less than his subsequent one (5.17), so we 
retained him in the analysis. Fig. 1 also shows a lack of clear relationship between 
seroconversion interval length and estimated SPVL (linear regression p = 0.559), further 
suggesting that our method is not systematically capturing VLs that are poor representations 
of SPVL for men with either short or long seroconversion intervals. We had at least one 
SPVL measure and information about role during seroconversion interval for 374 men; 
Table 2 shows demographic characteristics for this sub-sample.
Seroconversion sexual role was estimated from reported numbers of insertive or receptive 
partners at the first HIV-1-positive visit. We classified individuals reporting receptive AI 
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with ≥1 partner and no insertive AI partners as ER, individuals reporting the reverse as EI, 
and individuals reporting each with ≥1 partner as RV. We use role behaviors in the 
seroconversion interval only since these are most directly related to virus acquisition, and, 
had we included role throughout the entire study, few men would have been anything other 
than role versatile.
Methods for obtaining and quantifying VL have been published previously (Mellors et al., 
1996). Statistical comparisons of MSPVL by subgroup were completed in Stata 13.1 using 
both Mann-Whitney and t-tests for the empirical analyses. Based on our model findings 
(described below), we performed three analyses, one comparing the SPVLs of EI men and 
all others, and another two stratifying based on different metrics for numbers of partners. 
Because our final sample sizes were quite small, we kept our statistical analysis purposefully 
simple; that is, we did not consider additional predictors of SPVL beyond sexual (e.g. host 
genotype), assuming that these other predictors should be un-correlated with this behavioral 
attribute.
3. Results
3.1. One-generation model
Below we lay out the behavior observed in our simulations from this model. We note that 
key aspects of this behavior can also be demonstrated mathematically, and we include this 
derivation (provided to us by a reviewer) in Supplement section S9.
The model considering only one sex act demonstrated little, if any, difference in MSPVL 
between newly-infected EI and ER men (both values slightly below 5.4, Fig. 2a). These 
values represent a rapid shift away from the source population mean of 4.5; individuals with 
higher SPVL transmit more easily, and this effect is not counter-balanced here by the trade-
off of shorter life expectancy. Many more ER than EI men become infected (n = 1493 vs. 
128, Fig. 2b).
At the other extreme, when negative men have 104 acts with one partner, there is also little 
difference in MSPVL of newly-infected EI and ER men (4.55 vs. 4.50). These values, 
approximately equal to the source population’s, reflect the fact that nearly every HIV-1-
positive man transmits to his one partner eventually, although transmissions generally take 
longer when the negative partner is insertive. MSPVL for EI men is slightly higher because 
there remain a few non-transmitting pairs involving receptive source partners with very low 
SPVL even after many acts.
Intermediate counts of coital acts do, however, yield a difference by role, with ER men 
averaging markedly lower SPVL. This difference peaks at 400 acts, with a 0.508 log10 
difference between the two groups.
When we consider the same scenarios, but allow HIV-1-negative men to re-select partners 
between acts, we see a different pattern: MSPVL equals ~5.35 for both groups, for any 
number of coital acts (Fig. 2c). However, the pattern of relative times until men become 
infected is similar to that of the previous model (Fig. 2d). Contrasting this set of scenarios 
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with those above, then, we see examples in which the same number of partners but different 
number of acts per partner leads to different MSPVL values by sexual role; however, 
different number of partners but the same number of acts per partner do not.
3.2. Network model
Fig. 3 shows results from our dynamic network model across different relationship lengths. 
Results show greater stochasticity than for the one-generation model; presumably this is at 
least in part because the explicit feedback added here (those newly infected are in the partner 
pool for other HIV-uninfected men) allows for small random differences to become 
compounded. Consistent with the one-generation model, we see little, if any, difference 
between EI and ER men at short relationship durations. Differences appear at longer 
durations, for example at 500 days (corresponding to roughly 200 acts per relationship; 
0.124 MSPVL difference). Other durations also show noteworthy differences by role, 
although some with overlapping confidence intervals. In contrast, RV men display SPVL 
values similar to those of ER men, presumably because their greatest risk (and most of their 
infections) comes from their acts of receptive AI. Differences between EI and ER men are 
generally smaller here than in the Bernoulli model for the same number of acts, where those 
comparisons are possible; for example, at around 1000 acts per relationship, the Bernoulli 
model displayed a difference of ~0.4 log10 SPVL, while the network model showed only 
~0.1. Presumably this is because the added realism of the latter, i.e. partial heritability and 
evolutionary feedback between role groups. As with the one-generation model, here EI men 
are by far the least likely to become infected.
3.3. MACS analysis
Since both models demonstrated that a difference in SPVL by sexual role was expected 
under some conditions, we proceeded with our empirical analyses. Given our model results, 
we hypothesized that EI men would have higher SPVL than either ER or RV men, 
combining the latter two for the analysis and switching to one-tailed tests given the 
directionality of our hypothesis.
The combined sample of ER and RV men has a MSPVL of 4.29 and the EI men had a nearly 
identical 4.28 (Mann-Whitney U test, p = 0.371). However, both of our models indicated that 
we should only expect a difference when considering men whose main risk comes from 
relationships containing many acts. We did not have access to data on acts per relationship, 
nor on relational duration. However, we had two different measures of numbers of AI 
partners reported by respondents, which we could use as proxies for acts per relationship, 
assuming that low partner counts correlate with higher acts per partnership. To add support 
to this supposition, we analyzed data from the two studies of MSM that formed the main 
sources for the behavioral parameters in our dynamic network model. Both yielded a strong 
and significant relationship in the expected direction; e.g. in one study (n = 949), men with 1 
partner in the last 6 months had a 56% chance of reporting 10+ acts per partner and a 19% 
chance of 1 act; for those with 5+ partners, the corresponding numbers were 11% and 54%, 
respectively (details in Supplement section S10). An additional literature review indicated 
that existing reports on this topic focus on acts per partnership per unit time, not acts in total, 
while our interest was in the latter given our model.
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Each of our two proxy measures is imperfect in different ways, but provides some insight. 
The first was the reported number of partners in the 6 months prior to the first HIV-1-
positive study visit. Given the short time frame, this measure showed relatively little 
variation, and is likely less reflective of long-term behavior. The other (available for the 344 
men in the 1984 cohort only) was the estimated number of receptive AI partners (i.e. 
individuals the respondent had receptive sex with) a respondent had in the 2 years before and 
6 months after their baseline visit, a proxy for risk commonly used in analyses of MACS 
data (Detels et al., 1994; Herbeck et al., 2015). In this case, the longer duration gives a more 
stable estimate for partner acquisition rates; however, its limitation to receptive partners 
introduces some confounding with our main dependent variable, sexual role. We note that it 
is possible for a man we classify as EI (i.e. reporting no receptive partners) to have a value > 
0 for this metric (i.e. reporting receptive partners), since the two measures represent different 
times, potentially years apart. Given this caveat, we conducted two sub-analyses. First, we 
compared ER/RV men with ≤3 estimated baseline receptive partners to EI men with an 
estimated 0 baseline receptive partners, under the assumption that the latter represent men 
who are consistently insertive in the long-term. Second, we tried a more symmetric model, 
considering a ≤3-partner cutoff for each group. Finally, we tried different cutoffs (≤ 3 vs. 10 
partners) for each analysis to see how sensitive our results were to this arbitrary cutoff and to 
balance the desire to limit to those with very few, long relationships with a need for larger 
sample sizes. We used non-parametric one-tailed Mann-Whitney tests given the small 
sample sizes and likely violation of distributional assumptions, but also repeated analyses 
using one-sided t-tests, with qualitatively similar findings.
Table 3 and Fig. 4 show these results. When considering partners in the previous 6 months, 
MSPVL was nearly identical between EI men and others for both partnership count cutoffs; 
differences were not significant. However, when considering estimated number of receptive 
partners over the earlier 2.5-year span, EI men had significantly higher SPVL than others. 
For example, with the 10-partner cutoff for both groups, EI men had MSPVL of 4.51 and 
others had 4.19. This difference (~0.3 log10 copies/mL) is considered clinically significant; a 
meta-analysis found it to translate into a 25% higher annual risk of progression to an AIDS-
defining illness (Modjarrad et al., 2008). Results were qualitatively insensitive to cutoff.
Bold = significant at p = 0.05. All distributions were compared using a two-sample 
Wilcoxon (a.k.a. Mann-Whitney) test with exact p-values, given the small sample sizes and 
potential violation of distributional assumptions in some cases. Means are those observed; 
pseudo-medians and confidence intervals were calculated using a one-sample Wilcoxon test. 
We also conducted a two-sample one-tailed t-test with Welch-Satterthwaite approximation 
(no assumption of equal variances) since this focuses more specifically on comparing 
means; results were qualitatively similar, although the fifth comparison became 
nonsignificant, at p = 0.055. All analyses were conducted using the stats package in R, using 
default settings for all parameters not mentioned. Note that pseudo-medians are all higher 
than observed means given that the underlying distributions are left-skewed. Using the 
internal definitions of the MACS data set, “receptive partner count” refers to the number of 
partners with whom the respondent had receptive anal intercourse.
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4. Discussion
To our knowledge, no previous study has considered differences in SPVL by sexual role 
among MSM, despite the clinical and epidemiological significance of this virological 
measure, and numerous studies among heterosexuals. Our one-generation model 
demonstrated that we might expect exclusively insertive (EI) men to have higher MSPVL 
than others, but only when partnerships are sufficiently long to involve numerous sex acts. In 
our dynamic simulation, which included many additional forms of realism, the impact of 
role on SPVL was smaller but still present at sufficiently long relationship durations. In the 
one-generation model, the gap closed again at very high (2000+) mean numbers of acts per 
relationship. We considered such high numbers for the sake of insight-building; for the more 
data-driven and computationally intensive dynamic model, we did not explore this range, 
and the gap in SPVL between EI men and others remained wide. It is crucial to remember, 
however, that in each case EI men were the least likely to become infected overall, as would 
be expected given the difference in transmission probabilities by role.
The logic behind these findings is subtle, and relies on consideration of two extremes: when 
there is only one act per relationship, and when there are very many (e.g. 104). In the former, 
transmission is biased towards those with high SPVL, but is biased equally by role. In the 
latter, nearly all partnerships eventually transmit, so there is no bias by SPVL or role. At 
intermediate numbers, the level of bias differs by role, as Fig. 2 illustrated. Here all MSM 
acquire high SPVL strains disproportionately, but EI men do so more disproportionately 
than others (see also Supplement Section S9 for further elaboration).
Acute infection, with its increased transmission probability, complicates this idea. Short 
relationships mean greater opportunity to become infected and then infect others during a 
brief window, facilitating transmission from individuals with high VL because of acute 
infection, but not necessarily high SPVL. Notably, however, our models that did (dynamic) 
and did not (one-generation) include infection stages showed the same pattern at short 
relationships, indicating that acute infection is not the main driver of these patterns.
Results from the MACS data analysis provided partial confirmation for our models. The 
unstratified analysis failed to demonstrate a difference between groups. However, this 
included men with relationships of all lengths, while our model only predicted a difference 
for longer relationships; in the earliest cohort especially, many very short relationships likely 
predominated (Rotello, 1997). We conducted two subsets of stratified analyses focusing on 
men with few (and presumed longer) relationships, and these consistently demonstrated the 
predicted pattern of higher SPVL in EI men, with significance.
One early MACS study (Phair et al., 1992), although not considering role or SPVL, found 
that rapid progressors had more partners. We interpret this finding as consistent with our 
assumption that more partners suggests shorter relationships, and our model finding that 
shorter relationships should lead to higher SPVL and faster progression. However, we note 
that dual or superinfection could also generate this pattern (Gottlieb et al., 2004).
Our work provides indirect evidence to support the notion that some of the SPVL differences 
by sex in heterosexual transmissions might be influenced by differences in acquisition risk. 
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This builds on recent findings that the transmission bottleneck leads to females being 
disproportionately infected by HIV-1 strains with amino acids residues associated with lower 
viral fitness (Carlson et al., 2014). It is worth noting that, even though some authors have 
found that the greater probability for male-to-female transmission than vice versa disappears 
after controlling for a variety of factors that foster greater acquisition probabilities in 
females (Hughes et al., 2012), it is the unadjusted probabilities that represent the full set of 
environmental conditions shaping viral evolution.
This analysis has several limitations. We lacked a direct measure for acts per partnership, 
and our proxies were both imperfect; this adds noise to our analysis, and potentially bias 
related to the fact that our measures of role and coital frequency were not independent, with 
ER men seeming to have more, and thus shorter, partnerships on average. Despite beginning 
with a large cohort, our final analyses involved small sample sizes. Ascertainment of sexual 
role was unlikely to have correctly classified everyone as it was based on reported partner 
counts instead of a direct survey question. Given the small sample sizes generated by our 
need for complete behavioral data and narrow seroconversion windows, we did not explore 
other predictors of SPVL that might have confounded our observed relationships; however, 
we note that, unlike analysis of SPVL in heterosexual transmission, where the insertive 
(male) and receptive (female) partners are expected to exhibit a host of systematic genetic 
and endocrinological differences, we have no such expectations for differences between 
MSM who exhibit different sexual roles. Our models did not consider that men likely have a 
mixture of relationship types (e.g. one long and many short), which might further complicate 
observed patterns. Furthermore, our models contained many parameters that were fixed at 
single values drawn from the literature, including the parameters governing the relationship 
between VL and transmission probability (Fraser et al., 2007). Our qualitative findings 
might vary under different values for any of these, and we did not conduct sensitivity 
analyses to explore this. Many factors that might vary across populations, such as the 
numbers of sexual partners, the use of condoms, the presence of co-circulating STIs, or the 
level of antiviral treatment or more recently pre-exposure prophylaxis, could alter the 
evolutionary landscape for HIV-1 considerably. However, the impact of this limitation is 
tempered by the fact that our models served primarily to build the insights used to guide the 
empirical analysis.
Our Bernoulli model contained two comparisons: one in which we compared scenarios with 
the same number of partners but different numbers of acts per partner; and one in which we 
compared scenarios with different numbers of partners but the same number of acts per 
partner. The former yielded differences in MSPVL by sexual role in some cases, while the 
latter did not. This led to us focusing on number of acts as our main explanatory variable for 
the empirical analysis, despite the fact that our actual measure was partner number, since we 
expect these to correlate (and demonstrated that they did in the main source studies that 
parametrized our network model). In reality, however, patterns of partner number and acts 
per partner are likely to be more complex than we fully explored, and interact with other 
network phenomena, e.g. through the presence of core groups—the tendency for those with 
many short-term partnerships to choose each other as partners disproportionately. We are in 
the process of conducting additional modeling work examining more complex relationships 
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among these phenomena, and examining additional relationships between partner number 
and SPVL in the MACS data in light of these model findings.
Our results suggest that EI men, although less likely to become infected than men who 
engage in receptive AI, could be disproportionately infected by more virulent strains and 
might thus face worse outcomes, including as much as a 25% higher probability of 
progression to AIDS per year (Modjarrad et al., 2008). In the modern era, availability of 
treatment may mask these differences in many settings, although universal treatment is still 
far from a reality, even among MSM in developed settings (Singh et al., 2014). Analyses of 
VL measures from additional cohorts, especially cohorts with data on the number of both 
insertive and receptive acts per partnership in the period before seroconversion, could help 
confirm this finding, as would further work identifying viral selection at the transmission 
bottleneck (Carlson et al., 2014). Nonetheless, it appears that insertive men in long-term 
relationships now have an additional reason not to be complacent about their HIV risks.
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Fig. 1. 
Seroconversion window and SPVL distributions, MACS sample.
Size of the seroconversion window reflects the duration in months between the last visit with 
HIV-1-negative test results and first visit with HIV-1-positive test results for men in our 
sample. SPVL is measured at the subsequent one or two visits, as described in the text.
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Fig. 2. 
Results from one-generation model.
Mean SPVL and number of individuals infected changes based on role and number of sex 
acts in the one-generation model. In each panel, role signifies the role of the initially HIV-1-
negative partner. In 2a and 2b, there was no partner change: individuals stayed in the same 
relationship for the duration of the modeled time. In 2c and 2d, individuals selected a new 
partner with every act. (a) Mean SPVL for each role group, without partner change; (b) 
Number of individuals infected for each role group, without partner change; (c) mean SPVL 
for each role group, with partner change; (d) number of individuals infected for each role 
group, with partner change.
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Fig. 3. 
Results from dynamic network model.
Data represent mean SPVL for each role group averaged across 50 simulations. Men are 
included if they are infected during years 2–5 of the simulation. Data are shown for 8 
scenarios differing in mean relations durations (50, 100, 500, 1000, 1500, 2000, 2500 and 
3000 days). There were on average 0.4 acts/day leading to roughly 20, 40, 200, 400, 600, 
800, 1000, and 1200 acts per scenario. Shaded areas represent 95% confidence intervals 
around the mean values, using standard assumptions of normal variation across simulations.
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Fig. 4. 
Distribution of SPVL by role at seroconversion, for men with lower partner numbers.
Results shown here are for the sub-analysis comparing EI men (n = 20) with ER or RV men 
(n = 91) who each have an estimated 10 or fewer receptive partners in the 2.5 years around 
baseline. Role category is based on behavior in the first HIV-1-positive visit. The exclusively 
insertive men’s mean = 4.51 and the exclusively receptive and role versatile men’s mean = 
4.19 (shown with dark lines). The small clustering at 3 for EI men and lack of tail below that 
might suggest an issue with detection threshold; however, this is not present in the ER/RV 
men, and we know of no explanation why detection thresholds would differ by sexual role.
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Table 1
Derivation of sample.
Variable N %
Conditions required for all analyses (nested) MACS Cohort total 7,087
Entered seronegative 4,124 / 7,084 58.2%
Seroconverted 712 / 4,124 17.3%
Seroconversion interval < 1 year 535 / 712 75.1%
Had SPVL information 435 / 535 81.3%
Had seroconversion interval role information 374 / 435 86.0%
Role distribution of sample Exclusively insertive (El) 46 / 374 12.3%
Role versatile (RV) 278 / 374 74.3%
Exclusively receptive (ER) 50 / 374 13.4%
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Table 2
Demographic characteristics of the MACS sample, individuals with set point viral load data and 
seroconversion role data available.
Categorical Variables Category n %
Age at Seroconversion < 30 106 28.3
30–39.9 174 46.5
40–49.9 73 19.5
≥50 21 5.6
Cohort (enrollment years) 1984 (1984–1985) 344 92.0
1987 (1987–1991) 11 2.9
2001 (2002–2003) 19 5.1
Race/ethnicity Black, non-Hispanic 32 8.6
Hispanic 25 6.7
Asian or Pacific Islander 2 0.5
White, non-Hispanic 315 84.2
City Baltimore 101 27.0
Chicago 87 23.3
Los Angeles 105 28.0
Pittsburgh 81 21.7
Continuous Variables Measurement Time n Mean Median IQR
Est. age at seroconversion Seroconversion interval midpoint 374 35.3 34.0 29.4 40.1
Plasma log10 viral load Visit 1 334 4.30 4.49 3.95 4.83
Visit 2 304 4.28 4.40 3.90 4.76
2-visit mean 264 4.31 4.47 3.94 4.75
Overall 374 4.29 4.45 3.92 4.76
Epidemics. Author manuscript; available in PMC 2019 May 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Stansfield et al. Page 23
Ta
bl
e 
3
R
es
ul
ts 
of
 M
AC
S 
ro
le
 a
na
ly
se
s. Ro
le
n
M
ea
n 
SP
V
L
Ps
eu
do
-m
ed
ia
n 
SP
V
L 
(95
%
 C
I)
p-
v
a
lu
e
A
ll 
in
di
v
id
ua
ls
El
46
4.
28
4.
36
 (4
.08
–4
.61
)
0.
37
1
 
"
ER
 o
r R
V
32
8
4.
29
4.
36
 (4
.28
–4
.44
)
6 
m
o.
 p
ar
tn
er
 co
un
t ≤
 3
El
30
4.
20
4.
28
 (3
.89
–4
.69
)
0.
55
4
 
"
ER
 o
r R
V
11
0
4.
33
4.
42
 (4
.29
–4
.53
)
6 
m
o.
 p
ar
tn
er
 co
un
t ≤
 1
0
El
39
4.
22
4.
31
 (3
.99
–4
.56
)
0.
48
8
 
"
ER
 o
r R
V
25
3
4.
26
4.
34
 (4
.24
–4
.43
)
30
 m
o.
 re
ce
pt
iv
e 
pa
rtn
er
 c
ou
nt
 =
 0
El
7
4.
65
4.
82
 (4
.04
–5
.05
)
0.
02
7
30
 m
o.
 re
ce
pt
iv
e 
pa
rtn
er
 c
ou
nt
 ≤
 3
ER
 o
r R
V
33
4.
05
4.
17
 (3
.79
–4
.45
)
30
 m
o.
 re
ce
pt
iv
e 
pa
rtn
er
 c
ou
nt
 =
 0
El
7
4.
65
4.
82
 (4
.04
–5
.05
)
0.
02
4
30
 m
o.
 re
ce
pt
iv
e 
pa
rtn
er
 c
ou
nt
 ≤
 1
0
ER
 o
r R
V
91
4.
19
4.
28
 (4
.10
–4
.43
)
30
 m
o.
 re
ce
pt
iv
e 
pa
rtn
er
 c
ou
nt
 ≤
 3
El
17
4.
49
4.
67
 (4
.02
–4
.93
)
0.
03
9
 
"
ER
 o
r R
V
33
4.
05
4.
17
 (3
.79
–4
.45
)
30
 m
o.
 re
ce
pt
iv
e 
pa
rtn
er
 c
ou
nt
 ≤
 1
0
El
20
4.
51
4.
68
 (4
.09
–4
.88
)
0.
01
7
 
"
ER
 o
r R
V
91
4.
19
4.
28
 (4
.10
–4
.43
)
Epidemics. Author manuscript; available in PMC 2019 May 28.
